Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wellsense Technologies is a medical technology company specializing in the prevention of hospital-acquired pressure injuries (HAPIs). The company's flagship product, the MAP System (Monitor Alert Protect), is the first clinically proven continuous bedside pressure mapping system designed to monitor patient-surface interface pressure. It utilizes a pressure-sensing mat placed on a patient's bed to provide real-time visual feedback to caregivers, identifying areas of high pressure and guiding effective patient repositioning. By automating the monitoring process, Wellsense helps healthcare facilities reduce the incidence of bedsores and improve overall patient safety. In 2021, the company was acquired by Medline Industries, integrating its technology into Medline's extensive skin health and pressure injury prevention portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wellsense Technologies.